Rejuran Program or Juvelook Program?
They are different product families, not interchangeable names. Compare composition, exact product, concern, area, timeline, risks and follow-up.
Open the comparison
PN · Product variant · Sessions · Recovery · Quote
Rejuran Program
confirm the product before the plan.
Rejuran Program is a product family, not one universal protocol. Confirm the exact variant, purpose, area, session plan, recovery and current itemised quotation with a physician.
- Starting point
- PN composition
- Recovery / timing
- Exact variant matters
- Plan
- Sessions after assessment
- Price / next step
- Recovery + follow-up plan
Direct answer
What is a Rejuran Program, and what should I confirm before treatment?
The manufacturer lists Rejuran Program as a PN (polynucleotide) medical device intended for temporary improvement of facial wrinkles.
Product variants and intended areas differ.
A physician should verify the exact product, local indication, treatment area, technique, medical history, session plan, risks, aftercare and follow-up before recommending treatment.
General information only. It is not a diagnosis or a treatment recommendation. Individual suitability and response vary.
- Manufacturer country
- South Korea
Product identity
Confirm the exact Rejuran Program product before comparing a plan.
The manufacturer lists several PN products with different packing units and compositions. Local registration and the product actually stocked still need confirmation.
- Rejuran Program
Base product · 2 cc syringe
The official page lists PN composition, 2 cc per syringe and two syringes per pack, with temporary improvement of facial wrinkles as the stated purpose.
- Rejuran Program i
Smaller 1 cc presentation
The manufacturer lists a 1 cc syringe and names the eye and perioral areas among several intended areas. This does not make every thin-skin concern suitable.
- Rejuran Program s
Separate 1 cc product
The official page lists PN composition and a 1 cc syringe. Confirm why this exact product, and not only the Rejuran Program brand name, is proposed.
- HB plus
1 mL syringe with PN + sodium hyaluronate + lidocaine
The official page lists a 1 mL syringe. HB plus is not the same formulation as base Rejuran Program, so confirm the exact box, ingredients, locally applicable use, allergy history and storage traceability.
Evidence quality
A retracted paper is not used to set expectations or sessions.
PubMed marks a commonly cited 2014 Rejuran Program paper as a retracted publication. This page keeps that status visible instead of repeating its protocol as clinical guidance.
- Status
The 2014 paper is retracted
Its participant count, treatment schedule, outcomes and safety conclusions are not used here to recommend treatment or predict results.
- What remains usable
Official pages support product identity
The manufacturer pages can support the displayed product names, packing units, listed compositions, storage information and stated intended purposes.
- What remains unknown
They do not establish an individual protocol
A product listing cannot decide suitability, area, amount, delivery method, number of sessions, recovery or response for a person.
- Page rule
No fixed session count from the archive
The old WordPress copy and retracted study are excluded from session and outcome claims. The written plan must come from current product verification and physician assessment.
Consultation sequence
Build the plan from the concern, not from a package count.
The number of syringes or sessions cannot safely be selected before the product, area, history, recovery window and review point are documented.
- 01
Name the concern and area
Separate wrinkle, texture, scar, dryness and volume questions. Similar-looking concerns may require different products or no injectable treatment.
- 02
Verify the box and variant
Record the exact product name, packing unit, batch traceability and why its locally applicable purpose fits the proposed area.
- 03
Review history and trade-offs
Discuss allergies, active skin problems, medicines, pregnancy or breastfeeding, previous injectables, pain and recovery constraints, plus reasonable alternatives.
- 04
Document one itemised plan
The written plan should state product, amount or syringe basis, area, sessions, aftercare, review point, escalation contact and current itemised quotation.
Start with the exact product, purpose and skin question.
A brand name alone does not establish the variant, area, session count or suitability.
Share medical and treatment history
Report allergies, pregnancy or breastfeeding, active skin problems, medicines and previous injectables or reactions.
Add relevant historyPlan sessions and recovery
Confirm the review point, expected short-term reactions, written aftercare and how to reach the clinic if symptoms worsen.
Start consultationPatient review and before-and-after images
Rejuran Program review and before-and-after images
Published with patient consent
This review gallery documents individual patients with before-and-after images and does not predict another person's outcome.
Case 01
- Documented interval
- 14 days
The image identifies the Program, but does not by itself establish the exact product variant, amount, treatment area, technique or complete treatment plan.
Individual results vary. Capture timing, lighting, expression, camera distance and angle may differ as part of real-world clinical photography. A physician consultation is required before treatment.
Questions
How many Rejuran Program sessions do I need?
There is no safe universal count online. The physician confirms the exact product, concern, area, response and review point before recommending a session plan.
What is the current Rejuran Program price?
Request a current itemised quotation naming the exact product, syringe or session basis, area, physician process, aftercare and follow-up. This page does not repeat an unverified promotion.
What reactions should I discuss?
Ask about product-specific risks and common injection reactions such as redness, swelling, bruising or tenderness, plus infection risk and the direct route for unusual, severe or worsening symptoms.
Is every Rejuran Program product the same?
No. The manufacturer publishes different Rejuran Program variants and packing units. Confirm the exact product and locally applicable intended use before treatment.
Why does this page not use the commonly cited 2014 Rejuran Program study to recommend sessions?
PubMed marks that paper as a retracted publication. Its protocol and outcome claims are therefore not used to recommend a session count or predict results. This page relies on current manufacturer information for product identity and requires an individual physician assessment for the plan.
Rejuran Program sources
Rejuran Program sourcesOfficial Rejuran Program product-family listOfficial Rejuran Program i product informationOfficial Rejuran Program s product informationOfficial Rejuran Program HB plus product informationPubMed record marking a commonly cited 2014 Rejuran Program paper as retractedPubMed retraction notice for the 2014 Rejuran Program paperOfficial clinic and contact information
Choose how to reach us.
Use the channel that works best for appointment coordination and general questions.
Messaging is not monitored as an emergency service. Language availability and response times can vary.